• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    More On CIPLA.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Cipla Limited (CIPLA.BO)

    -BSE
    625.30 Down 4.35(0.69%) Dec 24, 5:29AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Cipla Limited
    Cipla House
    Peninsula Business Park
    Mumbai, 400013
    India - Map
    Phone: 91 22 2482 6000
    Fax: 91 22 2482 6893
    Website: http://www.cipla.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Cipla Limited manufactures and sells pharmaceutical and personal care products in India and internationally. The company offers active pharmaceutical ingredients; and formulations in therapeutic areas, such as allergy, analgesic, anti malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, HIV-AIDS, hormones and steroids, iron chelators, musculoskeletal, neuropsychiatry, nutritional and ophthalmic products, oncology, respiratory, urology, and womenÂ’s health, as well as steroids and hormones. It also provides veterinary products for various animals, including companion, equine, general care, live stock, and poultry. In addition, the company offers inhaled medication and devices comprising metered dose inhalers with dose indicators, dry powder inhalers, nasal sprays, nebulisers, non-electrostatic spacers, and infant and baby masks. It exports raw materials, intermediates, prescription drugs, OTC drugs, and veterinary products to approximately 170 countries worldwide. Cipla Limited was founded in 1935 and is based in Mumbai, India.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cipla Limited

    Key Executives 
     PayExercised
    Mr. Subhanu Saxena , 49
    Managing Director, Global Chief Exec. Officer and Director
    216.88MN/A
    Mr. Rajesh Garg , 47
    Global Chief Financial Officer, Exec. Director and Member of Mergers & Acquisitions Committee
    N/AN/A
    Mr. Mital Sanghvi ,
    Chief Compliance Officer and Company Sec.
    N/AN/A
    Mr. Murali Neelakantan ,
    Global Gen. Counsel
    N/AN/A
    Mr. S. Radhakrishnan CA,
    Whole-Time Director, Member of Mergers & Acquisitions Committee, Member of Audit Committee, Member of Stakeholders Relationship Committee, Member of Corp. Social Responsibility Committee and Member of Share Committee
    36.69MN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.